• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学方法在 COVID-19 中的应用:基于领域的文献综述。

Multi-omics approach to COVID-19: a domain-based literature review.

机构信息

National Institute for Infectious Diseases, "Lazzaro Spallanzani" - IRCCS, Via Portuense, 292, 00149, Rome, Italy.

Dept. Biology, University of Rome Tor Vergata, Via della Ricerca scientifica 1, Rome, Italy.

出版信息

J Transl Med. 2021 Dec 7;19(1):501. doi: 10.1186/s12967-021-03168-8.

DOI:10.1186/s12967-021-03168-8
PMID:34876157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8649311/
Abstract

BACKGROUND

Omics data, driven by rapid advances in laboratory techniques, have been generated very quickly during the COVID-19 pandemic. Our aim is to use omics data to highlight the involvement of specific pathways, as well as that of cell types and organs, in the pathophysiology of COVID-19, and to highlight their links with clinical phenotypes of SARS-CoV-2 infection.

METHODS

The analysis was based on the domain model, where for domain it is intended a conceptual repository, useful to summarize multiple biological pathways involved at different levels. The relevant domains considered in the analysis were: virus, pathways and phenotypes. An interdisciplinary expert working group was defined for each domain, to carry out an independent literature scoping review.

RESULTS

The analysis revealed that dysregulated pathways of innate immune responses, (i.e., complement activation, inflammatory responses, neutrophil activation and degranulation, platelet degranulation) can affect COVID-19 progression and outcomes. These results are consistent with several clinical studies.

CONCLUSIONS

Multi-omics approach may help to further investigate unknown aspects of the disease. However, the disease mechanisms are too complex to be explained by a single molecular signature and it is necessary to consider an integrated approach to identify hallmarks of severity.

摘要

背景

随着实验室技术的快速进步,在 COVID-19 大流行期间,产生了大量的组学数据。我们的目的是利用组学数据来突出特定途径的参与,以及细胞类型和器官的参与,在 COVID-19 的病理生理学中,并突出它们与 SARS-CoV-2 感染的临床表型的联系。

方法

分析基于域模型,其中域是指一个概念存储库,有助于总结多个不同层次涉及的生物途径。在分析中考虑了相关的域:病毒、途径和表型。为每个域定义了一个跨学科的专家工作组,以进行独立的文献范围审查。

结果

分析表明,先天免疫反应失调的途径(即补体激活、炎症反应、中性粒细胞激活和脱颗粒、血小板脱颗粒)会影响 COVID-19 的进展和结果。这些结果与几项临床研究一致。

结论

多组学方法可以帮助进一步研究疾病的未知方面。然而,疾病机制过于复杂,不能仅用单个分子特征来解释,因此有必要考虑采用综合方法来确定严重程度的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/1157399e732d/12967_2021_3168_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/a9a400924c57/12967_2021_3168_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/1029ca0fd914/12967_2021_3168_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/1157399e732d/12967_2021_3168_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/a9a400924c57/12967_2021_3168_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/1029ca0fd914/12967_2021_3168_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c83a/8650273/1157399e732d/12967_2021_3168_Fig3_HTML.jpg

相似文献

1
Multi-omics approach to COVID-19: a domain-based literature review.多组学方法在 COVID-19 中的应用:基于领域的文献综述。
J Transl Med. 2021 Dec 7;19(1):501. doi: 10.1186/s12967-021-03168-8.
2
Progress in understanding COVID-19: insights from the omics approach.对 COVID-19 的认识进展:组学方法的启示。
Crit Rev Clin Lab Sci. 2021 Jun;58(4):242-252. doi: 10.1080/10408363.2020.1851167. Epub 2020 Dec 29.
3
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
4
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.COVID-19 严重程度与抗体 Fc 介导的固有免疫功能的差异有关。
mBio. 2021 Apr 20;12(2):e00281-21. doi: 10.1128/mBio.00281-21.
5
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.新型冠状病毒肺炎:基于网络的方法模型分析病毒-宿主相互作用,研究 SARS-CoV-2 感染的发病机制。
J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w.
6
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.针对 SARS-CoV-2 刺突受体结合域和核衣壳的异源抗体及其对 COVID-19 免疫的影响。
JCI Insight. 2020 Sep 17;5(18):142386. doi: 10.1172/jci.insight.142386.
7
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.新型冠状病毒肺炎与血管紧张素转换酶 2 的关系:范围综述。
Adv Exp Med Biol. 2021;1321:53-68. doi: 10.1007/978-3-030-59261-5_5.
8
Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).新型冠状病毒肺炎(COVID-19)的特征、诊断和治疗的免疫学方面。
J Biomed Sci. 2020 Jun 4;27(1):72. doi: 10.1186/s12929-020-00663-w.
9
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.SARS-CoV-2 感染的支气管上皮细胞中的蛋白编码和长非编码 RNA(lncRNA)转录组阐明了干扰素和炎症反应的作用。
Genes (Basel). 2020 Jul 7;11(7):760. doi: 10.3390/genes11070760.
10
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.

引用本文的文献

1
Potential Resistance Mechanisms Exhibited by Cystic Fibrosis Patients Against SARS-CoV-2.囊性纤维化患者对SARS-CoV-2表现出的潜在抵抗机制。
Viruses. 2025 Jun 27;17(7):919. doi: 10.3390/v17070919.
2
Innate immune response in COVID-19: single-cell multi-omics profile of NK lymphocytes in a clinical case series.COVID-19 的先天免疫反应:临床病例系列中 NK 淋巴细胞的单细胞多组学特征。
Cell Commun Signal. 2024 Oct 15;22(1):496. doi: 10.1186/s12964-024-01867-5.
3
COVID-19: A complex disease with a unique metabolic signature.COVID-19:一种具有独特代谢特征的复杂疾病。

本文引用的文献

1
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.COVID19 疾病图谱,一个病毒 - 宿主相互作用机制的计算知识库。
Mol Syst Biol. 2021 Oct;17(10):e10387. doi: 10.15252/msb.202110387.
2
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.寻找与 COVID-19 相关的途径:通过 SARS-CoV-2-宿主相互作用组确认发病机制。
Cell Death Dis. 2021 Aug 12;12(8):788. doi: 10.1038/s41419-021-03881-8.
3
Immune determinants of COVID-19 disease presentation and severity.
PLoS Pathog. 2023 Nov 9;19(11):e1011787. doi: 10.1371/journal.ppat.1011787. eCollection 2023 Nov.
4
Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19.多平台分析揭示了成人与儿童严重急性 COVID-19 全身发病机制的不同驱动因素。
Nat Commun. 2023 Apr 4;14(1):1638. doi: 10.1038/s41467-023-37269-3.
5
Lung T cell response in COVID-19.COVID-19 中的肺 T 细胞反应。
Front Immunol. 2023 Feb 16;14:1108716. doi: 10.3389/fimmu.2023.1108716. eCollection 2023.
6
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.基于尿液的 COVID-19 和细菌脓毒症引起的 ARDS 的多组学比较分析。
Mol Med. 2023 Jan 26;29(1):13. doi: 10.1186/s10020-023-00609-6.
7
Pitfalls in complement analysis: A systematic literature review of assessing complement activation.补体分析的陷阱:评估补体激活的系统文献回顾。
Front Immunol. 2022 Oct 18;13:1007102. doi: 10.3389/fimmu.2022.1007102. eCollection 2022.
8
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS.新型冠状病毒肺炎与细菌性脓毒症诱发的急性呼吸窘迫综合征基于尿液的多组学比较分析
medRxiv. 2022 Aug 10:2022.08.10.22277939. doi: 10.1101/2022.08.10.22277939.
9
The immune response as a double-edged sword: The lesson learnt during the COVID-19 pandemic.免疫反应如双刃剑:COVID-19 大流行期间汲取的教训。
Immunology. 2022 Nov;167(3):287-302. doi: 10.1111/imm.13564. Epub 2022 Sep 5.
10
Network Embedding Across Multiple Tissues and Data Modalities Elucidates the Context of Host Factors Important for COVID-19 Infection.跨多种组织和数据模态的网络嵌入阐明了对COVID-19感染重要的宿主因子的背景。
Front Genet. 2022 Jul 8;13:909714. doi: 10.3389/fgene.2022.909714. eCollection 2022.
COVID-19 疾病表现和严重程度的免疫决定因素。
Nat Med. 2021 Jan;27(1):28-33. doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.
4
Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19).急性冠状病毒病 2019(COVID-19)康复后 3 个月的综合健康评估。
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098. doi: 10.1093/cid/ciaa1750.
5
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.COVID-19 中的免疫、内皮损伤和补体诱导的凝血异常。
Nat Rev Nephrol. 2021 Jan;17(1):46-64. doi: 10.1038/s41581-020-00357-4. Epub 2020 Oct 19.
6
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.新型冠状病毒肺炎肺血管内凝血病变的免疫机制
Lancet Rheumatol. 2020 Jul;2(7):e437-e445. doi: 10.1016/S2665-9913(20)30121-1. Epub 2020 May 7.
7
An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.血浆溶血磷脂酰胆碱在血管系统中的促炎和抗炎特性的最新综述。
Int J Mol Sci. 2020 Jun 24;21(12):4501. doi: 10.3390/ijms21124501.
8
COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.新型冠状病毒肺炎:基于网络的方法模型分析病毒-宿主相互作用,研究 SARS-CoV-2 感染的发病机制。
J Transl Med. 2020 Jun 10;18(1):233. doi: 10.1186/s12967-020-02405-w.
9
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.COVID-19 疾病图谱,构建 SARS-CoV-2 病毒-宿主相互作用机制的计算知识库。
Sci Data. 2020 May 5;7(1):136. doi: 10.1038/s41597-020-0477-8.
10
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.